Salvage esophagectomy after failure of definitive radiochemotherapy for esophageal cancer.

Authors : Farinella E, Safar A, Nasser HA, Bouazza F, Liberale G, Paesmans M, Marechal R, Van Laethem JL, Hendlisz A, VanHoutte P, El Nakadi I
Year : 2016
Journal : J Surg Oncol
Volume : 114
Pages : 833-837

Missing metastases as a model to challenge current therapeutic algorithms in colorectal liver metastases.

Authors : Lucidi V, Hendlisz A, Van Laethem JL, Donckier V
Year : 2016
Journal : World J Gastroenterol
Volume : 22
Pages : 3937-44

Too little benefit for too much toxicity: rethinking the adjuvant development model in colon cancer.

Authors : Hendlisz A, Bleiberg H
Year : 2016
Journal : Curr Opin Oncol
Volume : 28(4)
Pages : 345-7

Monitoring metabolic response using FDG PET-CT during targeted therapy for metastatic colorectal cancer.

Authors : Woff E, Hendlisz A, Garcia C, Deleporte A, Delaunoit T, Maréchal R, Holbrechts S, Van den Eynde M, Demolin G, Vierasu I, Lhommel R, Gauthier N, Guiot T, Ameye L, Flamen P
Year : 2016
Journal : Eur J Nucl Med Mol Imaging
Volume : 43(10)
Pages : 1792-801

Phase II study of necitumumab plus modified FOLFOX6 as first-line treatment in patients with locally advanced or metastatic colorectal cancer.

Authors : Elez E, Hendlisz A, Delaunoit T, Sastre J, Cervantes A, Varea R, Chao G, Wallin J, Tabernero J
Year : 2016
Journal : Br J Cancer
Volume : 114(4)
Pages : 372-80

Long-acting octreotide as secondary prevention of chemotherapy-induced diarrhea: proof of concept.

Authors : VAN DEN Heuvel B, Peeters M, Hendlisz A, Van den Eynde M, Machiels G, Dero I, Geboes K, De Man M, Hendrickx K, Delaunoit T, Monsaert E, Vanderstraten E, Van Laethem JL, Lybaert W, Holbrechts S, Rolfo C
Year : 2016
Journal : Minerva Chir

Tumour-educated circulating monocytes are powerful candidate biomarkers for diagnosis and disease follow-up of colorectal cancer.

Authors : Hamm A, Prenen H, Van Delm W, Di Matteo M, Wenes M, Delamarre E, Schmidt T, Weitz J, Sarmiento R, Dezi A, Gasparini G, Rothé F, Schmitz R, Dhoore A, Iserentant H, Hendlisz A, Mazzone M
Year : 2016
Journal : Gut
Volume : 65(6)
Pages : 990-1000

The Prognostic Significance of Metabolic Response Heterogeneity in Metastatic Colorectal Cancer.

Authors : Hendlisz A, Deleporte A, Delaunoit T, Maréchal R, Peeters M, Holbrechts S, Van den Eynde M, Houbiers G, Filleul B, Van Laethem JL, Ceyssens S, Barbuto AM, Lhommel R, Demolin G, Garcia C, El Mansy H, Ameye L, Moreau M, Guiot T, Paesmans M, Piccart-Gebhart M, Flamen P
Year : 2015
Journal : PLoS One
Volume : 10
Pages : e0138341

Evolution In the therapeutic strategy of localized resectable pancreatic ductal adenocarcinoma.

Authors : Van Daele D, Puleo F, Dumont R, Polus M, Loly C, Martinive P, Meunier P, Collignon J, Hendlisz A, Maréchal R, Louis E, Van Laethem JL
Year : 2015
Journal : Rev Med Suisse
Volume : 11
Pages : 1543-8

Colorectal cancer: ten years of illusion of progress but advances are on the horizon].

Authors : Shaza L, Charette N, Hendlisz A
Year : 2015
Journal : Rev Med Brux
Volume : 36
Pages : 263-6

Radioembolisation and portal vein embolization before resection of large hepatocellular carcinoma.

Authors : Bouazza F, Poncelet A, Garcia CA, Delatte P, Engelholm JL, Gomez Galdon M, Deleporte A, Hendlisz A, Vanderlinden B, Flamen P, Donckier V
Year : 2015
Journal : World J Gastroenterol
Volume : 21
Pages : 9666-70

A first-in-human phase I and pharmacokinetic study of CP-4126 (CO-101), a nucleoside analogue, in patients with advanced solid tumours.

Authors : Venugopal B, Awada A, Evans TR, Dueland S, Hendlisz A, Rasch W, Hernes K, Hagen S, Aamdal S
Year : 2015
Journal : Cancer Chemother Pharmacol
Volume : 76(4)
Pages : 785-92

Chemotherapy treatment patterns and neutropenia management in gastric cancer.

Authors : Kalinka-Warzocha E, Plazas JG, Mineur L, Salek T, Hendlisz A, Decosta L, Vogl FD, Passalacqua R
Year : 2015
Journal : Gastric Cancer
Volume : 18(2)
Pages : 360-7

Of art and science: is personalized medicine getting personal enough?

Authors : Hendlisz A
Year : 2015
Journal : Curr Opin Oncol
Volume : 27(4)
Pages : 349-50

Regorafenib assessment in refractory advanced colorectal cancer: RegARd-C study protocol.

Authors : Hendlisz A, Deleporte A, Vandeputte C, Charette N, Paesmans M, Guiot T, Garcia C, Flamen P
Year : 2015
Journal : BMJ Open
Volume : 5(3)
Pages : e007189

Erratum: Preoperative chemosensitivity testing as Predictor of Treatment benefit in Adjuvant stage III colon cancer (PePiTA): Protocol of a prospective BGDO (Belgian Group for Digestive Oncology) multicentric study.

Authors : Hendlisz A, Golfinopoulos V, Deleporte A, Paesmans M, El Mansy H, Garcia C, Peeters M, Annemans L, Vandeputte C, Maetens M, Van den Eynde M, Maréchal R, Borbath I, Dresse D, Houbiers G, Fried M, Awada A, Piccart-Gebhart M, Van Laethem JL, Flamen P
Year : 2015
Journal : BMC Cancer
Volume : 15
Pages : 173

Y90 radioembolization of colorectal cancer liver metastases: response assessment by contrast-enhanced computed tomography with or without PET-CT guidance.

Authors : Vouche M, Salem R, Miller FH, Lemort M, Vanderlinden B, De Becker D, Hendlisz A, Flamen P
Year : 2015
Journal : Clin Imaging
Volume : 39(3)
Pages : 454-62

Pooled analysis of the surgical treatment for colorectal cancer liver metastases.

Authors : Veereman G, Robays J, Verleye L, Leroy R, Rolfo C, van Cutsem E, Bielen D, Ceelen W, Danse E, De Man M, Demetter P, Flamen P, Hendlisz A, Sinapi I, Vanbeckevoort D, Ysebaert D, Peeters M
Year : 2015
Journal : Crit Rev Oncol Hematol
Volume : 94(1)
Pages : 122-135

Guidelines for time-to-event end-point definitions in trials for pancreatic cancer. Results of the DATECAN initiative (Definition for the Assessment of Time-to-event End-points in CANcer trials).

Authors : Bonnetain F, Bonsing B, Conroy T, Dousseau A, Glimelius B, Haustermans K, Lacaine F, Van Laethem JL, Aparicio T, Aust D, Bassi C, Berger V, Chamorey E, Chibaudel B, Dahan L, de Gramont A, Delpero JR, Dervenis C, Ducreux M, Gal J, Gerber E, Ghaneh P, Hammel P, Hendlisz A, Jooste V, Labianca R, Latouche A, Lutz M, Macarulla T, Malka D, Mauer M, Mitry E, Neoptolemos J, Pessaux P, Sauvanet A, Tabernero J, Taieb J, Van Tienhoven G, Gourgou-Bourgade S, Bellera C, Mathoulin-Pélissier S, Collette L
Year : 2014
Journal : Eur. J. Cancer
Volume : 50(17)
Pages : 2983-93

In times of crisis, go liquid!

Authors : Hendlisz A, Deleporte A, Vandeputte C
Year : 2014
Journal : Curr Opin Oncol
Volume : 26(4)
Pages : 440